CLINICAL_TRIALS
trial_result
· 2016-01-20
Clinical Trial Update: Randomized Trial of Induction Therapies in High Immunological Risk Kidney Transplant Recipients [Phase 4]
Summary
This Phase 4 randomized trial update reports results from induction therapies in high immunological risk kidney transplant recipients.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Cincinnati | Conditions: Kidney Transplantation | Phase 4 | Status: COMPLETED | Results posted: 2016-01-20